Center-Authored Papers

Filters: Author is Fenske, Timothy S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Chen RW, Li H, Bernstein SH, Kahwash S, Rimsza LM, Forman SJ, Constine L, Shea TC, Cashen AF, Blum KA et al..  2016.  RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.. British journal of haematology. Abstract
E
Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ et al..  2015.  Gray zone lymphoma with features intermediate between classical hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort.. American journal of hematology. Abstract
F
Fenske TS, Zhang M-J, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M et al..  2014.  Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(4):273-81. Abstract
Fenske TS, Hamadani M, Cohen JB, Costa LJ, Kahl B, Evens AM, Hamlin PA, Lazarus HM, Petersdorf E, Bredeson C.  2016.  Allogeneic hematopoietic cell transplantation as curative therapy for patients with non-Hodgkin lymphoma: increasingly successful application to older patients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(9):1543-1551. Abstract
G
Ghosh N, Karmali R, Rocha V, Woo Ahn K, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, DeLima M et al..  2016.  Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
H
Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen Y-B et al..  2014.  Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Hamadani M, Saber W, Woo Ahn K, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN et al..  2013.  Impact of Pretransplant Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Haverkos BM, Abbott D, Hamadani M, Armand P, Flowers ME, Merryman R, Kamdar M, Kanate AS, Saad A, Mehta A et al..  2017.  PD-1 blockade for relapsed lymphoma post allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.. Blood. Abstract
K
Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E et al..  2017.  Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.. British journal of haematology.
Kanate AS, Mussetti A, Kharfan-Dabaja MA, Ahn KW, DiGilio A, Beitinjaneh A, Chhabra S, Fenske TS, Freytes C, Gale RP et al..  2015.  Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors.. Blood. Abstract
L
Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros JL et al..  2017.  Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2017722157. Abstract
Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, Cassaday R, Chavez JC, Song K, Zelenetz AD, Gandhi M et al..  2015.  Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.. Cancer. Abstract
M
Maramattom LV, Hari PN, Burns LJ, Carreras J, Arcese W, Cairo MS, Costa LJ, Fenske TS, Lill M, Freytes CO et al..  2012.  Autologous and Allogeneic Transplantation for Burkitt Lymphoma Outcomes and Changes in Utilization: A Report from the Center for International Blood and Marrow Transplant Research.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Maziarz RT, Wang Z, Zhang M-J, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM et al..  2013.  Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.. British journal of haematology. 162(5):648-56. Abstract
P
Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ et al..  2014.  Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.. Blood. 124(15):2354-61. Abstract
S
Smith SM, Burns LJ, van Besien K, Le Rademacher J, He W, Fenske TS, Suzuki R, Hsu JW, Schouten HC, Hale GA et al..  2013.  Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(25):3100-9. Abstract
W
Wildes TM, Farrington L, Yeung C, Harrington AM, Foyil KV, Liu J, Kreisel F, Bartlett NL, Fenske TS.  2014.  Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers.. Therapeutic advances in hematology. 5(1):3-12. Abstract